The global, science-based company, dsm-firmenich Animal Nutrition and Health announced on Aug. 15, the Canadian Food Inspection Agency (CFIA) approved the use of a novel enzyme, fumonisin esterase, to help swine and poultry producers manage mycotoxins in feed.
“Fumonisin esterase is for the degradation of fumonisins present in swine and poultry feed,” Paige Gott, Ph.D., dsm-firmenich Strategic Product Manager, said in a release. “This approval expands dsmfirmenich’s commitment to innovation in mycotoxin risk management.”
dsm-firmenich will offer a new product which includes the fumonisin esterase called Mycofix® FUMzyme® for use in swine and poultry diets in Canada. More information will be available in the coming weeks.
“This will be the first product ever to be approved for degrading fumonisins in feed in the Canadian market,” Gott said. “Mycotoxins can have various negative effects on swine and poultry production. Fumonisins are the second most prevalent group of mycotoxins worldwide. Fumonisins are commonly found in livestock diets in North America and can interact with other mycotoxins and have synergistic effects that impair health and productivity of livestock and poultry. They are of increasing importance with more frequent extreme weather events in the region.”
